Becerde, Merygrace O.

HRN: 12-19-23  Sex: Female

Patient Encounter


Audit Details

Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
07/03/2024
CLINDAMYCIN 150MG/ML, 4ML (AMP)
07/03/2024
07/09/2024
IV
300mg
Q6
Hack Wound Secondary To Hacking(bolo)
Waiting Final Action 

Indication:  Prophylaxis    Type of Infection:  Bone & Joint    Compliance to guidelines: Compliant To Guidelines

Initial appropriateness: Yes   

Final appropriateness: No  Wrong Dose 

Overall appropriateness: No  Wrong Dose

Intervention



Type of Intervention done:

                    

           


Acceptance: